Glutaminyl cyclase is an enzymatic modifier of the CD47 SIRP axis and a target for cancer immunotherapy

Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPĪ± axis and a target for cancer immunotherapy

22:42 EST 4 Mar 2019 | Nature Publishing

More From BioPortfolio on "Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPĪ± axis and a target for cancer immunotherapy"